Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |